Richard Sackler
48Patents
26h-index
28Co-inventors
85Inventor score
Filing activity: May 27, 1982 → Jul 10, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5478577A | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level | Human Necessities | 409 | Expired |
| US5672360A | Method of treating pain by administering 24 hour oral opioid formulations | Human Necessities | 399 | Expired |
| US6143322A | Method of treating humans with opioid formulations having extended controlled release | Human Necessities | 298 | Expired |
| US5747060A | Prolonged local anesthesia with colchicine | Human Necessities | 268 | Expired |
| US7332182B2 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant | Human Necessities | 254 | Expired |
| US5942241A | Formulations and methods for providing prolonged local anesthesia | Human Necessities | 248 | Expired |
| US6524607B1 | Formulations and methods for providing prolonged local anesthesia | Human Necessities | 218 | Expired |
| US7157103B2 | Pharmaceutical formulation containing irritant | Human Necessities | 212 | Expired |
| US6248345A | Prolonged anesthesia in joints and body spaces | Emerging Cross-Sectional Technologies | 191 | Expired |
| US6534081B2 | Prolonged anesthesia in joints and body spaces | Emerging Cross-Sectional Technologies | 188 | Expired |
| US6921541B2 | Formulations and methods for providing prolonged local anesthesia | Human Necessities | 151 | Expired |
| US8017148B2 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent | Human Necessities | 99 | Active |
| US6552031B1 | Synergistic analgesic combination of oxycodone and rofecoxib | Human Necessities | 98 | Expired |
| US5716611A | Emollient antimicrobial formulations containing povidone iodine | Emerging Cross-Sectional Technologies | 95 | Expired |
| US8652497B2 | Pharmaceutical formulation containing irritant | Human Necessities | 90 | Active |
| US7727557B2 | Pharmaceutical formulation containing irritant | Human Necessities | 89 | Active |
| US7790215B2 | Sustained-release gel coated compositions | Human Necessities | 85 | Active |
| US8652515B2 | Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent | Human Necessities | 72 | Active |
| US6699908B2 | Methods for providing safe local anesthesia | Human Necessities | 69 | Expired |
| US6673367B1 | Controlled/modified release oral methylphenidate formulations | Human Necessities | 69 | Expired |
| US7083808B2 | Controlled/modified release oral methylphenidate formulations | Human Necessities | 65 | Expired |
| US6521259B1 | Formulations and methods for providing prolonged local anesthesia | Human Necessities | 49 | Expired |
| US6514516B1 | Formulations and methods for providing prolonged local anesthesia | Human Necessities | 48 | Expired |
| US6017963A | Formulation for intranasal administration | Human Necessities | 41 | Expired |
| US7125561B2 | Compartmentalized dosage form | Human Necessities | 40 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.